Michal Kidacki, MD, PhD
InstructorDownloadHi-Res Photo
Cards
Appointments
Dermatology
Primary
Contact Info
About
Titles
Instructor
Appointments
Dermatology
InstructorPrimary
Other Departments & Organizations
Education & Training
- Transitional Year
- Mercy Catholic Medical Center (2020)
- PhD
- Penn State College of Medicine
- MD
- Penn State College of Medicine
- BA
- Rutgers University, Biology (2009)
- AA
- Union County College, Biology (2007)
Board Certifications
Dermatology
- Certification Organization
- AB of Dermatology
- Original Certification Date
- 2023
Research
Overview
Medical Research Interests
Hair Follicle; Immune System
ORCID
0000-0002-3279-5974
Research at a Glance
Yale Co-Authors
Frequent collaborators of Michal Kidacki's published research.
Publications Timeline
A big-picture view of Michal Kidacki's research output by year.
Matthew Vesely, MD, PhD
Christina Cho, PhD
Francesc Lopez-Giraldez, PhD
Gavitt Woodard, MD
Jacky Yeung, MD, FAANS
Jonathan Leventhal, MD
20Publications
197Citations
Publications
2025
Spatial transcriptomics reveals differential inflammatory pathways in discoid lupus erythematosus and lichen planus
Kidacki M, Cho C, Lopez-Giraldez F, Breidbart R, Jaiswal A, Lee M, Chowdhury S, Damsky W, Chen L, Vesely M. Spatial transcriptomics reveals differential inflammatory pathways in discoid lupus erythematosus and lichen planus. Journal Of Investigative Dermatology 2025 PMID: 40113031, DOI: 10.1016/j.jid.2025.02.148.Peer-Reviewed Original ResearchAltmetricPD-1H (VISTA) expression in cutaneous squamous cell carcinoma is correlated with T cell infiltration and activation
Kidacki M, Cho C, Lopez-Giraldez F, Huang B, He J, Gaule P, Chen L, Vesely M. PD-1H (VISTA) expression in cutaneous squamous cell carcinoma is correlated with T cell infiltration and activation. Journal Of Investigative Dermatology 2025 PMID: 39983979, DOI: 10.1016/j.jid.2025.01.030.Peer-Reviewed Original ResearchAltmetricConceptsCutaneous squamous cell carcinomaPD-L1 expressionT cell infiltrationPD-L1Squamous cell carcinomaVISTA expressionPD-1HCell carcinomaT cellsBlockade of PD-1Proliferation marker Ki-67Multiplexed quantitative immunofluorescencePD-L1 coexpressionTreatment of cutaneous squamous cell carcinomaControl T cellsPreclinical cancer studiesMyeloid cell functionImmunosuppressive microenvironmentPD-1Receptor antagonismKi-67Individual tumorsGranzyme B.Clinical trialsCancer clinical trials
2024
207 Spatial transcriptomic profiling non-small cell lung cancer reveals potential drivers of CTL exclusion and dysfunction, and identifies novel predictive biomarkers for checkpoint blockade therapy
Cho C, Lopez-Giraldez F, Huang B, He J, Woodard G, Badri T, Kidacki M, Vesely M, Wang G, Ofori-Ntiamoah G, Ng E, Chen L. 207 Spatial transcriptomic profiling non-small cell lung cancer reveals potential drivers of CTL exclusion and dysfunction, and identifies novel predictive biomarkers for checkpoint blockade therapy. 2024, a236-a236. DOI: 10.1136/jitc-2024-sitc2024.0207.Peer-Reviewed Original ResearchSpatial Transcriptomics in Inflammatory Skin Diseases Using GeoMx Digital Spatial Profiling: A Practical Guide for Applications in Dermatology
Cho C, Haddadi N, Kidacki M, Woodard G, Shakiba S, Yıldız-Altay Ü, Richmond J, Vesely M. Spatial Transcriptomics in Inflammatory Skin Diseases Using GeoMx Digital Spatial Profiling: A Practical Guide for Applications in Dermatology. JID Innovations 2024, 5: 100317. PMID: 39559817, PMCID: PMC11570843, DOI: 10.1016/j.xjidi.2024.100317.Peer-Reviewed Original ResearchCitationsConceptsDigital spatial profilingInflammatory skin diseaseGeoMx Digital Spatial ProfilerSkin diseasesDiscoid lupus erythematosusNanoString GeoMx Digital Spatial ProfilingImmune milieuImmune microenvironmentLichen planusLupus erythematosusSingle cell RNA sequencingAberrant inflammationCell RNA sequencingSkin disease pathogenesisDisease pathogenesisManufacturer's guidelinesIndicators of diseaseDiseaseSpatial transcriptomics platformSkinTissue processing
2023
Immune Inhibitory Molecule PD-1 Homolog (VISTA) Colocalizes with CD11b Myeloid Cells in Melanoma and Is Associated with Poor Outcomes
Vesely M, Kidacki M, Gaule P, Gupta S, Chan N, Han X, Yeung J, Chen L. Immune Inhibitory Molecule PD-1 Homolog (VISTA) Colocalizes with CD11b Myeloid Cells in Melanoma and Is Associated with Poor Outcomes. Journal Of Investigative Dermatology 2023, 144: 106-115.e4. PMID: 37562584, DOI: 10.1016/j.jid.2023.07.008.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsCD11b myeloid cellsImmune inhibitory moleculesPD-L1 expressionVISTA expressionMyeloid cellsFuture potential therapeutic targetsPD-L1/B7Tumor microenvironmentInhibitory moleculesMultiplexed quantitative immunofluorescencePrimary cutaneous melanomaImmunosuppressive tumor microenvironmentNegative prognostic biomarkerCurrent clinical trialsPotential therapeutic targetCause mortalityCritical cell typesPD-L1Poor outcomeTreatment of cancerMelanoma recurrenceCutaneous melanomaClinical trialsPrognostic biomarkerT cells
2021
Iatrogenic calcinosis cutis from extravasated phosphate-containing solution treated with topical sodium thiosulfate
Xie CB, Kidacki M, Ring N, Panse G, Leventhal JS. Iatrogenic calcinosis cutis from extravasated phosphate-containing solution treated with topical sodium thiosulfate. JAAD Case Reports 2021, 17: 31-33. PMID: 34692964, PMCID: PMC8517711, DOI: 10.1016/j.jdcr.2021.09.013.Peer-Reviewed Case Reports and Technical NotesCitationsAltmetric
2020
Twist2 is NFkB-responsive when p120-catenin is inactivated and EGFR is overexpressed in esophageal keratinocytes
Lehman H, Kidacki M, Stairs D. Twist2 is NFkB-responsive when p120-catenin is inactivated and EGFR is overexpressed in esophageal keratinocytes. Scientific Reports 2020, 10: 18829. PMID: 33139779, PMCID: PMC7608670, DOI: 10.1038/s41598-020-75866-0.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsEsophageal squamous cell carcinomaCancer typesYear of diagnosisSquamous cell carcinomaEsophageal keratinocytesOverexpression of EGFRHuman esophageal keratinocytesAggressive cell typesFatal cancer typePoor prognosisCell carcinomaTwist2 expressionEGFR overexpressionEGFREMT-inducing geneNFkBResponsive targetsTwist2Paucity of researchCell typesPresent studyKeratinocytesP120-cateninOverexpressionComplete loss
2019
E‐cadherin and p120ctn protein expression are lost in hidradenitis suppurativa lesions
Nelson AM, Cong Z, Gettle SL, Longenecker AL, Kidacki M, Kirby JS, Adams DR, Stairs DB, Danby FW. E‐cadherin and p120ctn protein expression are lost in hidradenitis suppurativa lesions. Experimental Dermatology 2019, 28: 867-871. PMID: 31107992, DOI: 10.1111/exd.13973.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsProtein expressionHS lesional skinPathogenesis of HSInflammatory skin diseaseJunction proteinsHidradenitis suppurativa lesionsInflammatory skin conditionNon-lesional skinSevere skin lesionsE-cadherinAdherens junction proteinsE-cadherin expressionHurley stageAtopic dermatitisLesional skinDesmosome sizeHS pathogenesisHS skinAcne vulgarisHS patientsSkin lesionsPilosebaceous unitSkin conditionsSkin diseasesHealthy skin1028 Deciphering the mechanism of action of isotretinoin in acne patients using next gene sequencing technologies
Thiboutot D, Kidacki M, Sarfo A, Schneider A, Albert I, Longenecker A, Cong Z, Nelson A. 1028 Deciphering the mechanism of action of isotretinoin in acne patients using next gene sequencing technologies. Journal Of Investigative Dermatology 2019, 139: s178. DOI: 10.1016/j.jid.2019.03.1104.Peer-Reviewed Original Research‘Invasive proliferative gelatinous mass’ of hidradenitis suppurativa contains distinct inflammatory components
Kidacki M, Cong Z, Flamm A, Helm K, Danby FW, Nelson AM. ‘Invasive proliferative gelatinous mass’ of hidradenitis suppurativa contains distinct inflammatory components. British Journal Of Dermatology 2019, 181: 192-193. PMID: 30597519, DOI: 10.1111/bjd.17541.Peer-Reviewed Original ResearchCitationsAltmetric
Academic Achievements & Community Involvement
Honors
honor Transitional Year Excellence Award
06/27/2020Other AwardMercy Catholic Medical CenterDetailsUnited Stateshonor Travel Grant
10/09/2018Other AwardSymposium on Hidradenitis Suppurativa AdvancesDetailsUnited Stateshonor Travel Award
10/09/2018Other AwardPenn State MD/PhD ProgramDetailsUnited Stateshonor Daniel Notterman Award
05/01/2016Other AwardPenn State UniversityDetailsUnited Stateshonor Travel Award
04/06/2016Other AwardPenn State MD/PhD ProgramDetailsUnited States